Shuangni Duan

Shuangni Duan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2025 in Dermatologic Therapy
Verified
Journal Article
Open access
LZLemei Zhu
Lemei Zhu
YLYuqing Liu
Yuqing Liu
ZGZhuo Gong
Zhuo Gong
BZBohua Zhu
Bohua Zhu
CZChenghao Zhang
Chenghao Zhang
PBPingping Bing
Pingping Bing
Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting approximately 20% of children and 10% of adults. While previous studies have linked AD to allergen exposure, disruption of the skin barrier, and Type 2 immune responses, the precise pathophysiology of AD remains elusive, significantly limiting the effectiveness of current treatments. Noncoding RNAs (ncRNAs), a diverse group of transcripts that do not encode proteins and account for at least 98% of the human genome, are implicated in numerous physiological and pathological processes. A growing body of evidence underscores the pivotal role of ncRNAs in the pathogenesis and progression of AD. This review offers a detailed synthesis of the latest insights into the involvement of ncRNAs in AD, as well as their potential as diagnostic biomarkers and therapeutic targets.

28 October 2022 in Emergency Medicine International
Verified
Journal Article
Open access
PDF file
YGYulin Guo
Yulin Guo
SHShun Hu
Shun Hu
XWXiaohui Wang
Xiaohui Wang
ZJZhe Jiang
Zhe Jiang
SDShuangni Duan
Shuangni Duan
FLFei Li
Fei Li
Backgrounds. The novel coronavirus disease 2019 (COVID-19) has caused a global pandemic. Pancreatic injuries have been reported in COVID-19 patients. The present meta-analysis was conducted to compare the morbidity and outcomes of AP between COVID-19 positive and negative patients. Methods. Databases including Cochrane Library, PubMed, and EMBASE were systematically searched (until July 3rd 2022). Studies with English abstracts comparing the severity and outcomes of AP between COVID-19 positive and negative patients were included. Mean differences or odds ratios with a 95% confidence interval were employed for assess variables. Risk of publication bias was assessed with funnel plots. Results. Data from 7 studies with a total of 2816 AP patients were included. COVID-19 positive was associated with higher incidences of pancreatic necrosis (OR = 1.65; 95% CI: 1.13 to 2.42, = 0.01; = 0.82 for heterogeneity) and persistent organ failure (OR = 6.87; 95% CI: 2.37 to 19.98, = 0.0004; = 0.12 for heterogeneity), especially cardiovascular failure (OR = 2.92; 95% CI: 1.66 to 5.14, = 0.0002; = 0.58 for heterogeneity) and acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) (OR = 3.03; 95% CI: 2.09 to 4.39, < 0.00001; = 0.20 for heterogeneity). COVID-19 infection induced a higher level of CRP (MD = 0.40; 95% CI: 0.16 to 0.64, = 0.001; < 0.00001 for heterogeneity) as well as coagulation disorders involving platelets, prothrombin time, activated partial thromboplastin time, and D-dimer (all < 0.05). During hospitalization, COVID-19 positive was associated with higher ICU admission rate (OR = 2.76; 95% CI: 1.98 to 3.85 < 0.00001; = 0.47 for heterogeneity). COVID-19 positive AP was associated with a higher mortality rate (OR = 3.70; 95% CI: 2.60 to 5.25, < 0.00001; = 0.12 for heterogeneity). Discussion. The number of included studies is limited and none is RCT, thus the risks of publication and selective bias could not be ignored. COVID-19 deteriorated the severity and clinical outcomes of AP, with a high incidence of morbidity and mortality.

8 November 2024 in IEEE Access
Verified
Journal Article
Open access
RZRuiming Zeng
Ruiming Zeng
BQBoan Qu
Boan Qu
Wei LiuWei Liu
Wei Liu
JLJianghao Li
Jianghao Li
HLHongshen Li
Hongshen Li
LZLemei Zhu
Lemei Zhu
Presents corrections to the paper, (Corrections to “FastLeakyResNet-CIR: A Novel Deep Learning Framework for Breast Cancer Detection and Classification”).